公开(公告)号：US20230090435A1

公开(公告)日：2023-03-23

申请号：US18056346

申请日：2022-11-17

申请人： Northeastern University

发明人： Kim Lewis ,  Yu imai ,  Quentin Favre-Godal ,  Akira Iinishi ,  Kirsten Meyer

IPC分类号： C07K7/06 ,  A61P31/04 ,  A61K45/06

摘要： Embodiments of the present invention relate to a novel compound of Formula (I) or stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, for use in treatment of infection caused by Gram-negative bacteria.

公开(公告)号：US11535648B2

公开(公告)日：2022-12-27

申请号：US17260934

申请日：2019-05-17

申请人： Northeastern University

发明人： Kim Lewis ,  Yu Imai ,  Quentin Favre-Godal ,  Akira Iinishi ,  Kirsten Meyer

IPC分类号： C07K7/06 ,  A61P31/04 ,  A61K45/06

摘要： Embodiments of the present invention relate to a novel compound of Formula (I) or stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, for use in treatment of infection caused by Gram-negative bacteria.

公开(公告)号：US20210261616A1

公开(公告)日：2021-08-26

申请号：US17260934

申请日：2019-05-17

申请人： Northeastern University

发明人： Kim Lewis ,  Yu Imai ,  Quentin Favre-Godal ,  Akira Iinishi ,  Kirsten Meyer

IPC分类号： C07K7/06 ,  A61K45/06 ,  A61P31/04

摘要： Embodiments of the present invention relate to a novel compound of Formula (I) or stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, for use in treatment of infection caused by Gram-negative bacteria.